It is important to note that sera from patients with some neurological diseases, particularly stiff person syndrome (SPS), contain high levels of both anti-GAD65 and anti-GAD67 [6], [7], and the anti-GAD reactivity in these patients may differ from that in T1D. This evidence concerns the gene GAD2 and stiff-person syndrome.